As of Oct 2, 2026 close
- Market cap
- $3.71B
- P/E (TTM)
- 17.75
- Forward P/E
- 34.60
- Dividend yield
- 0.58%
- 52-week range
- $5.69$13.79
- Volume (live)
- —
- Avg. volume (3M)
- 2.70M
Organon & Co. (OGN) Stock Price & Financial Analysis
Organon & Co. Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $13.71 - $13.75 |
|---|---|
| 52-Week High | $13.79 |
| 52-Week Low | $5.69 |
| Open | $13.71 |
| Volume (last close) | 1.92M |
| Average Volume (3M) | 2.70M |
| Market Cap | 3.71B |
|---|---|
| Shares Outstanding | 270.45M |
| P/E Ratio (TTM) | 17.75 |
| Forward P/E | 34.60 |
| Price to Sales (P/S) | 0.61 |
| Price to Book (P/B) | 3.69 |
| EV/EBITDA | 8.85 |
| Revenue (TTM) | 6.13B |
|---|---|
| Net Income (TTM) | 209.00M |
| Free Cash Flow (TTM) | 567.00M |
| EPS (TTM) | $0.79 |
| Profit Margin | 3.41% |
| Operating Margin | 18.79% |
| Return on Equity (ROE) | 20.78% |
| Debt to Equity | 8.50 |
| 50-Day MA | $13.68 |
|---|---|
| 200-Day MA | $10.89 |
| 52-Week Change | +25.41% |
| Annual Dividend | $0.08 |
|---|---|
| Dividend Yield | 0.58% |
| Payout Ratio | 10.09% |
| Last Dividend Ex-Date | Aug 14, 2026 |
Organon & Co. at a Glance
Organon & Co. (OGN) has a market capitalization of $3.71B. The stock trades at 17.8× trailing earnings, 34.6× forward earnings and 0.6× sales. Over the trailing twelve months it earned $209.00M on revenue of $6.13B (a 3.4% profit margin) and generated $567.00M of free cash flow. Revenue fell 2.5% year over year.
It holds $1.13B in cash and securities against $8.55B of debt, a net debt position of $7.42B.
Organon & Co. pays a quarterly dividend totaling $0.08 per share a year, a 0.58% yield, with a 10% payout ratio.
The share price is up 24.6% over the past year. At $13.72 it sits near the top of its 52-week range of $5.69 to $13.79, above its 200-day moving average of $10.89.
Frequently Asked Questions About Organon & Co.
What is the current stock price for OGN?
As of the Oct 2, 2026 close, OGN stock trades at $13.72. The 52-week range is $5.69–$13.79, with a day range of $13.71–$13.75.
What is the P/E ratio for OGN?
Organon & Co.'s trailing P/E ratio is 17.8, meaning investors pay $17.8 for every $1 of annual earnings. The forward P/E is 34.6, reflecting analyst expectations for future earnings. Organon & Co. operates in the Healthcare sector.
Does OGN pay dividends?
Yes, Organon & Co. pays a 0.58% annual dividend yield ($0.08 per share). The payout ratio is 10.1%. The last ex-dividend date was 2026-08-14.
What do analysts recommend for OGN?
Analyst ratings and recommendations for OGN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of OGN?
Organon & Co.'s market capitalization is $3.71B, classifying it as a mid-cap company. Organon & Co. operates in the Healthcare sector within the Drug Manufacturers - General industry.